Lactate dehydrogenase kinetics predict chemotherapy response in recurrent metastatic nasopharyngeal carcinoma

BACKGROUND: Lactate dehydrogenase (LDH) is a known prognostic biomarker for the endemic variant of nasopharyngeal carcinoma (NPC). Here, we investigate whether serial changes in LDH level between chemotherapy (CT) cycles are associated with tumour response to CT. METHODS: Patients with biopsy-proven...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Luo, Sim, Adelene Y. L., Wu, Yongzhong, Liang, Zhongguo, Li, Kaiguo, Du, Youqin, Ong, Enya H. W., Tan, Hong Qi, Wee, Joseph T. S., Xie, Yue, Shu, Xiaolei, Wang, Ying, Chua, Melvin L. K., Zhu, Xiaodong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7672732/
https://www.ncbi.nlm.nih.gov/pubmed/33240398
http://dx.doi.org/10.1177/1758835920970050

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7672732/
https://www.ncbi.nlm.nih.gov/pubmed/33240398
http://dx.doi.org/10.1177/1758835920970050

Ejemplares similares